1-5 of 5
Oliver G. Ottmann, M.D.
Close
Sort by
Journal Articles

Phase Ib Study of Oral Panobinostat In Combination with 5-Azacitidine (5-aza) In Patients with Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)

Pierre Fenaux, MD, PhD, Daniel J DeAngelo, MD, PhD, Guillermo Garcia-Manero, MD, Michael Lübbert, MD, PhD, Anand P. Jillella, MD, Mikkael A. Sekeres, MD, MS, Ivo J. Winiger, MD, Margaret Squier, MD, PhD, Xiaodong Li, PhD, Oliver G. Ottmann, M.D.
Journal: Blood
Blood (2010) 116 (21): 4957.
https://doi.org/10.1182/blood.V116.21.4957.4957
Published: 2010
Journal Articles

Treatment of Patients up to 60 Years with High Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial.

Jürgen Krauter, MD, Gerhard Heil, M.D., Dieter Hoelzer, M.D., Oliver G. Ottmann, M.D., Hans Martin, M.D., Michael Lubbert, M.D., Jurgen Finke, M.D., Wolfgang F.W. Heit, M.D., Walter Fiedler, M.D., Lothar Kanz, M.D., Gunter Schlimok, M.D., Hartmut H. Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Arnold Ganser, M.D.
Journal: Blood
Blood (2006) 108 (11): 433.
https://doi.org/10.1182/blood.V108.11.433.433
Published: 2006
Journal Articles

Prospective Randomized Comparison of High Dose AraC and AutoPBSCT as Late Consolidation for Patients ≤60 Years with Standard Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial.

Arnold Ganser, MD, Jürgen Krauter, M.D., Dieter Hoelzer, M.D., Oliver G. Ottmann, M.D., Hans Martin, M.D., Michael Lubbert, M.D., Jurgen Finke, M.D., Wolfgang F.W. Heit, M.D., Walter Fiedler, M.D., Lothar Kanz, M.D., Gunter Schlimok, M.D., Hartmut H. Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Gerhard Heil, M.D.
Journal: Blood
Blood (2006) 108 (11): 607.
https://doi.org/10.1182/blood.V108.11.607.607
Published: 2006
Journal Articles

The Acute Promyelocytic Leukemia-Associated Fusion Protein PML/RAR Blocks t-RA-Induced Differentiation in a Subset of Cells with Stem Cell Potential.

Xiaomin Zheng, M.Sc., Anita Seshire, M.Sc., Elena Puccetti, PhD, Hilal Gul, M.Sc., Tim Beissert, PhD, Dieter Hoelzer, M.D., PhD, Oliver G. Ottmann, M.D., Reinhard Henschler, M.D., Martin Ruthardt, M.D.
Journal: Blood
Blood (2004) 104 (11): 1175.
https://doi.org/10.1182/blood.V104.11.1175.1175
Published: 2004
Journal Articles

The Reciprocal t(9;22)-Translocation Products ABL/BCR Have Leukemogenic Potential Independently from BCR/ABL.

Xiaomin Zheng, M.Sc., Saskia Güller, M.D., Gesine Bug, M.D., Bithia Grace, M.Sc., Roxana Bistrian, M.Sc., Dieter Hoelzer, M.D., PhD, Oliver G. Ottmann, M.D., Reinhard Henschler, M.D., Martin Ruthardt, M.D.
Journal: Blood
Blood (2004) 104 (11): 214.
https://doi.org/10.1182/blood.V104.11.214.214
Published: 2004